Specialist Segments
- Healthtech, Fintech and other selected Vertical Specific Software
- Application Software
- Infrastructure Software
- Payments
The Technology and Payments sector is large and fast growing with fundamental mega trends re-shaping businesses such as regulation, digitalisation and modern AI tools that are all creating opportunities for an experienced sector-focused private equity investor backing fast-growing software & payment companies.
Nordic Capital has invested in this sector for over 20 years. It is one of the most experienced Technology & Payments investors in Northern Europe focusing on companies with great potential to drive superior growth and benefit from fundamental market trends.
Hear more about our focus on Technology & Payments in this video:
24
Technology & Payments platform investments since 2001*
€5.8bn
of equity capital deployed*
14,200
people employed by Nordic Capital-backed Tech & Payment companies**
€3.1bn
of revenues generated in current Technology & Payment portfolio**
Investment Director
Investment Director
Partner
Partner
Operations Managing Director
Investment Director
Partner | Chief Investment Process Officer | Head of Technology & Payments
Managing Director
Investment Director
Managing Director
Investment Director
Partner
Investment Director
Operating Partner, Head of Operations Advisory
Investment Director
Managing Director, Country Coverage Manager for Norway
Investment Director
Investment Director
Since acquisition, Signicat has recorded accelerated growth and international expansion. Asger Hattel, CEO, takes us through the transformative changes in the past few years and describes Nordic Capital’s contribution to the value-creation plan. "They’ve been a good sparring partner on the strategy and in the execution," he said.
Based on a platform carve-out from one of the large Nordic banks, Bambora was created with the aim of creating a leading player within the payment services sector through a carefully crafted acquisition strategy and significant investment in products, capability and the organisational framework.
* Cross-fund investments counted as one. Including CV1, EVO and HealthTech companies
** Including HealthTech companies